http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0514077-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
filingDate 2005-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6977df5a366198752fcb938255a3f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798c32ca2174c40817890b0886b73710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd060e6ba6871f8502d5d3eeaa6bbad1
publicationDate 2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0514077-A
titleOfInvention benzyloxy derivatives as maob inhibitors
abstract Benzyloxy derivatives as MAOB inhibitors. The present invention relates to compounds of general formula (I); where R¬ ¬ is halogen; R¬ ¬ is -C (O) NH ~ 2 ~, -C (NH ~ 2 ~) = N-OH, -C (O) CH ~ 2 ~ Br, -C (O) N (CH ~ 3 ~) OCH ~ 3 - or lower alkyl (O) -, or is a 5 membered heteroaryl group containing 2 or 3 heteroatoms selected from the group consisting of N, O or S, optionally substituted by R¬ ¬, where R ¬ ¬ is lower alkyl, -NRR "or -C (O) R; R is NR <R>," lower alkyl, or lower alkoxy; R < 3 > are independently hydrogen or lower alkyl; as well as pharmaceutically acceptable salts thereof for the treatment of diseases, which are mediated by monoamine oxidase B inhibitors, for example Alzheimer's disease and senile dementia.
priorityDate 2004-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID945941
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25750
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID338445
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404730
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 38.